“We’re seeing certainly real-time vaccine diplomacy start to play out, with China in the lead in terms of being able to manufacture vaccines within China and make them available to others,” said Krishna Udayakumar, founding director of the Duke Global Health Innovation Center at Duke University. “Some of them donated, some of them sold, and some of them sold with debt financing associated with it.
Like many other countries, Chile received far fewer doses of the Pfizer vaccine than first promised. In the month after its vaccination program began in late December, only around 150,000 of the 10 million Pfizer doses the South American country ordered arrived. China’s vaccines, which can be stored in standard refrigerators, are attractive to countries like Indonesia, a sweltering nation that straddles the equator and could struggle to accommodate the ultracold storage needs of vaccines like Pfizer’s.
Serbia became the first country in Europe to start inoculating its population with China’s vaccines in January. The country has so far purchased 1.5 million doses of Sinopharm’s vaccine, which makes up the majority of the country’s supply, and smaller amounts of Russia’s Sputnik V and Pfizer’s vaccines.
Neighboring Hungary, impatient over delays in the European Union, soon became the first country in the EU to approve the same Chinese vaccine. On Sunday, Hungarian Prime Minister Viktor Orban got the Sinopharm shot, after recently saying he trusted the Chinese vaccine the most. But Zayed ultimately decided to get the shot after conducting more research. A doctor at his hospital called colleagues in the United Arab Emirates, which had approved the same shot, and they met with Egyptian health officials.
With Chinese vaccines, “for a lot of people, the first thing you think about is ‘Made in China,’ and that doesn’t give you much assurance,” said Joy Zhang, a professor at the University of Kent in the UK who studies the ethics of emerging science. Those concerns have been exacerbated by confusion around the efficacy of Sinovac’s shot. In Turkey, where Sinovac conducted part of its efficacy trials, officials have said the vaccine was 91% effective. However, in Brazil, officials revised the efficacy rate in late-stage clinical trials from 78% to just over 50% after including mild infections.
Probably because china knows what covid19 is in detail.😋😋😋
Ap please go fys !!
CCP vaccine will only work for a few weeks like the rest of the cheap s**t they produce
CNN ABC NYTIMES WASHINGTONPOST MSNBC CBSNEWS FOXNEWS Reuters ABC6 CBSPhilly NBCPhiladelphia TelemundoNews FOX29philly 69News phl17 Check this out! FOLKS. STOP YOUR B.S ATTACKS ON ASIANS PLEASE! W.H.O reported the Corona Virus point of origin IS NOT CHINA.
India has sent Vaccine to... 47 countries and 27 others are in the pipeline. VaccineMaitri Covishield Covaxin
Create a problem to sell the cure.. brilliant
Amazing how the country that created COVID miraculously had a very effective vaccine within a few months 🤔
lol
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.